FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to application of membrane vesicles of multipotent stromal cells for restoration and enhancement of mitochondrial function by delivering functionally active mitochondria into cells of mammals for therapy of mitochondrial dysfunction.
EFFECT: membranous vesicles of multipotent stromal cells are induced by cytochalasin B, surrounded by bilipid cytoplasmic membrane, carry superficial cytoplasmic receptors (CD90, CD29, CD44, CD73), have diameter ranging from 100 to 2,000 nanometers and contain functionally active mitochondria.
1 cl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| METHOD FOR INCREASING THE PROLIFERATIVE POTENTIAL OF THREE-DIMENSIONAL TUMOR CELL CULTURES | 2021 |
|
RU2782600C1 |
| TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
| METHOD OF PRODUCING A MEDICINAL PREPARATION BASED ON HUMAN CELL VESICLES | 2015 |
|
RU2605853C1 |
| TUMOR EXTRACELLULAR VESICLES FOR TREATMENT OF ORGAN FAILURE | 2022 |
|
RU2791356C1 |
| METHOD FOR SPINAL CORD REGENERATION STIMULATION BY MEANS OF VESICLES PREPARED FROM MESENCHYMAL STEM CELLS OF ADIPOSE TISSUE | 2020 |
|
RU2739912C1 |
| METHOD FOR ACTIVATING CYTOTOXIC T-LYMPHOCYTES IN A POPULATION OF BLOOD MONONUCLEAR CELLS USING MEMBRANE VESICLES OBTAINED FROM GENETICALLY MODIFIED TUMOR CELLS OF M14 MELANOMA WITH OVEREXPRESSION OF INTERLEUKIN 2 | 2022 |
|
RU2790867C1 |
| METHOD OF HOMINAL MITOCHONDRIAL GENOME COPYING IN YARROWIA LIPOLYTICA YEAST CELLS | 2016 |
|
RU2660715C2 |
| METHOD OF SELECTING MEDICINAL PRODUCTS FOR PHARMACOLOGICAL INDUCTION OF MITOCHONDRIAL DYSFUNCTION IN MACROPHAGES FOR ANTITUMOR THERAPY | 2023 |
|
RU2810558C1 |
| METHOD FOR SELECTING MITOCHONDRIA FOR EXPERIMENTAL THERAPY OF B16-F10 MELANOMA | 2022 |
|
RU2794762C1 |
